Analogic Corporation (NASDAQ:ALOG) Files An 8-K Results of Operations and Financial Condition

0

Analogic Corporation (NASDAQ:ALOG) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition

On December6, 2017, Analogic Corporation (the “Registrant”) announced its financial results for the fiscal quarter ended October31, 2017. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

Item 2.02 Financial Statements and Exhibits

Exhibit No.

Description

99.1 Press Release dated December6, 2017


ANALOGIC CORP Exhibit
EX-99.1 2 d508303dex991.htm EX-99.1 EX-99.1 Exhibit 99.1   News Release FOR IMMEDIATE WORLDWIDE RELEASE For Further Information: Investor and Financial Media Contact: Mark Namaroff Senior Director of Investor Relations and Corporate Communications (978) 326-4058 [email protected] Analogic Announces Results for the First Quarter Ended October 31,…
To view the full exhibit click here

About Analogic Corporation (NASDAQ:ALOG)

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company’s Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company’s Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.

An ad to help with our costs